Seeing Is Believing
IMGN is currently covered by 9 analysts with an average price target of $34.08. This is a potential upside of $2.85 (9.13%) from yesterday's end of day stock price of $31.23.
ImmunoGen's activity chart (see below) currently has 75 price targets and 97 ratings on display. The stock rating distribution of IMGN is 69.23% BUY and 30.77% HOLD.
Analysts average stock forecasts to be materialized ratio is 92.72% with an average time for these price targets to be met of 539.22 days.
Highest price target for IMGN is $29, Lowest price target is $4, average price target is $34.08.
Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 01-Dec-2023. First documented stock forecast 06-Aug-2012.
Currently out of the existing stock ratings of IMGN, 18 are a BUY (69.23%), 8 are a HOLD (30.77%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$27
1 years 17 days ago
(01-Dec-2023)
4/4 (100%)
$9.83 (57.25%)
134
Hold
$31
$-0.23 (-0.74%)
$26
1 years 17 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
224
Hold
$31
$-0.23 (-0.74%)
$12
1 years 17 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
293
Hold
$24
$-7.23 (-23.15%)
$6
1 years 17 days ago
(01-Dec-2023)
5/6 (83.33%)
$-5.32 (-18.14%)
721
Hold
$25
$-6.23 (-19.95%)
1 years 17 days ago
(01-Dec-2023)
4/5 (80%)
$-4.32 (-14.73%)
1442
What is IMGN (ImmunoGen) average time for price targets to be met?
Which analyst has the current highest performing score on IMGN (ImmunoGen) with a proven track record?
Which analyst has the most public recommendations on IMGN (ImmunoGen)?
Which analyst is the currently most bullish on IMGN (ImmunoGen)?
Which analyst is the currently most reserved on IMGN (ImmunoGen)?